TCRT
NASDAQ
US
Alaunos Therapeutics, Inc. - Common Stock
$2.93
▼ $-0.02
(-0.68%)
Vol 17K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$7.2M
ROE
-168.0%
Margin
-29440.0%
D/E
0.00
Beta
-1.25
52W
$1–$6
Wall Street Consensus
6 analysts · Mar 20250
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
CELZ
Creative Medical Technology Holdings Inc
$5.1M
PMCB
PharmaCyte Biotech Inc
$7.3M
SYBX
Synlogic Inc
$13.1M
LIMN
Liminatus Pharma Inc
$16.5M
XBIO
Xenetic Biosciences Inc
$5.0M
CDIO
Cardio Diagnostics Holdings Inc
$4.9M
BRTX
BioRestorative Therapies Inc
$10.4M
ERNA
Ernexa Therapeutics Inc
$9.4M
ENSC
Ensysce Biosciences Inc
$3.3M
Earnings
Beat rate: 50.0%
Next Report
May 13, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | — | — |
| Dec 2023 | $-4.59 | $-4.90 | $-0.31 |
| Sep 2023 | $-5.36 | $-6.00 | $-0.65 |
| Jun 2023 | $-6.73 | $-6.00 | +$0.73 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -168.0% | -169.3% | -168.0% | -168.0% | -168.0% | -168.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -29440.0% | -29440.0% | -29440.0% | -29440.0% | -29440.0% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.48 | 1.00 | 3.48 | 3.48 | 3.48 | 2.92 |
Key Ratios
ROA (TTM)
-120.7%
P/S (TTM)
720.88
P/B
1.5
EPS (TTM)
$-2.29
CF/Share
$-0.14
Rev Growth 3Y
-70.7%
52W High
$6.20
52W Low
$1.31
$1.31
52-Week Range
$6.20
How does TCRT compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
TCRT valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
720.9
▲
5510%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.5
▼
40%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
TCRT profitability vs Biotechnology peers
ROE
-168.0%
▼
150%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-29440.0%
▼
10167%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-120.7%
▼
158%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
TCRT financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
2.9
▼
34%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
-1.3
▼
229%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
TCRT fundamentals radar
TCRT
Peer median
Industry
TCRT profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
TCRT vs peers: key metrics
Latest News
No related news yet